Wall Street analysts expect Obalon Therapeutics Inc (NASDAQ:OBLN) to announce earnings of ($0.50) per share for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Obalon Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.44) and the lowest estimate coming in at ($0.56). Obalon Therapeutics reported earnings per share of ($0.46) during the same quarter last year, which suggests a negative year over year growth rate of 8.7%. The company is scheduled to report its next earnings report on Wednesday, August 1st.
On average, analysts expect that Obalon Therapeutics will report full year earnings of ($2.19) per share for the current financial year, with EPS estimates ranging from ($2.29) to ($2.09). For the next fiscal year, analysts anticipate that the firm will report earnings of ($2.03) per share, with EPS estimates ranging from ($2.06) to ($1.99). Zacks Investment Research’s EPS averages are an average based on a survey of sell-side analysts that follow Obalon Therapeutics.
Top Heal Care Stocks To Own For 2019: SigmaTron International, Inc.(SGMA)
Advisors' Opinion:- [By Max Byerly]
Media coverage about SigmaTron International (NASDAQ:SGMA) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. SigmaTron International earned a coverage optimism score of 0.25 on Accern’s scale. Accern also gave news coverage about the technology company an impact score of 47.5987310031013 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Top Heal Care Stocks To Own For 2019: Solar Senior Capital Ltd.(SUNS)
Advisors' Opinion:- [By Joseph Griffin]
Hercules Technology Growth Capital (NYSE: HTGC) and Solar Senior Capital (NASDAQ:SUNS) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings.
- [By Max Byerly]
Solar Senior Capital Ltd (NASDAQ:SUNS) announced a monthly dividend on Thursday, June 7th, Wall Street Journal reports. Investors of record on Thursday, June 21st will be paid a dividend of 0.1175 per share by the asset manager on Tuesday, July 3rd. This represents a $1.41 dividend on an annualized basis and a yield of 8.46%. The ex-dividend date of this dividend is Wednesday, June 20th. This is a boost from Solar Senior Capital’s previous monthly dividend of $0.12.
Top Heal Care Stocks To Own For 2019: Avago Technologies Limited(AVGO)
Advisors' Opinion:- [By Ethan Ryder]
Broadcom (NASDAQ:AVGO) had its price target trimmed by Bank of America from $300.00 to $285.00 in a report released on Tuesday morning. The firm currently has a buy rating on the semiconductor manufacturer’s stock.
- [By Logan Wallace]
Traders sold shares of Broadcom Inc (NASDAQ:AVGO) on strength during trading hours on Wednesday. $86.14 million flowed into the stock on the tick-up and $164.35 million flowed out of the stock on the tick-down, for a money net flow of $78.21 million out of the stock. Of all equities tracked, Broadcom had the 13th highest net out-flow for the day. Broadcom traded up $2.07 for the day and closed at $240.56
- [By Chris Dier-Scalise]
Strong balance sheets and consistent demand for discrete processors and GPUs across the board has kept the likes of Micron and semi-behemoth NVIDIA trucking past the rest of the market, both posting top and bottom line revenue results for seven consecutive quarters. Other companies like Intel and Qualcomm, whose processor sales rely mainly on the sales figures of PCs and devices they’re included in, have also surged ahead as market leaders. Intel Corporation (NASDAQ: INTC) posted record annual revenue over the course of 2017 and both Intel and Qualcomm remain leading candidates in the M&A game despite the block of latter’s deal with Broadcom Ltd. (NASDAQ: AVGO).
- [By ]
Though not without blemishes, Google's report is (in the views of this observer) fairly encouraging overall, given that shares went into earnings trading at reasonable multiples for a company with Google's growth rates and competitive positioning in several highly valuable markets. Here are key takeaways from the Q1 report and subsequent earnings call:
Google emphatically put to rest any concerns that its mobile search and YouTube ad momentum was about to meaningfully slow. Paid ad clicks on Google's own sites and apps (they include video ad views that technically aren't "clicks") rose 59% annually, outpacing Q4's 48% growth. This more than offset a 19% drop in cost per click (slightly worse than Q4's 16% drop), the result of mobile search and YouTube ad prices being lower on average than PC search ad prices. CFO Ruth Porat noted mobile search was once more the largest driver behind Google's ad growth, and both Porat and CEO Sundar Pichai sounded upbeat about search ad trends. Though there have been worries about Amazon.com's (AMZN) impact on Google Search, both due to the growth of Amazon's ad business and the tendency of Amazon shoppers to go straight to its site/apps, Google Search remains a one-of-a-kind online marketing vehicle -- including for many businesses that are either competing against Amazon or operate in an industry that Amazon isn't involved in. And like Amazon, Facebook (FB) and others, Google is benefiting from the steady shift of advertising dollars towards online channels. TAC -- the ad revenue-sharing payments Google makes to the likes of phone OEMs, carriers and publishers -- remains a real headwind. For the second quarter in a row, it equaled 24% of Google's ad revenue versus 22% a year earlier. Moreover, Porat forecast TAC's share of ad revenue on Google's own sites and apps (13% in Q1) will continue rising, albeit at a slower pace starting in Q2. A revamped search ad revenue-sharing deal with Apple (AAPL) is believ
Top Heal Care Stocks To Own For 2019: Companhia Brasileira de Distribuicao(CBD)
Advisors' Opinion:- [By Logan Wallace]
Companhia Brasileira de Distribuicao (NYSE: CBD) and Alimentation Couche-Tard Inc Class B (OTCMKTS:ANCUF) are both retail/wholesale companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.
- [By Lisa Levin] Gainers TransEnterix, Inc. (NYSE: TRXC) rose 28.8 percent to $4.03 in pre-market trading after the company disclosed that it has received the FDA clearance for expanded indications for its Senhance Surgical System. Global Eagle Entertainment Inc. (NASDAQ: ENT) rose 15.6 percent to $2.30 in pre-market trading. Companhia Brasileira de Distribuição (NYSE: CBD) rose 13.2 percent to $24.20 in pre-market trading. ZTO Express (Cayman) Inc. (NYSE: ZTO) rose 12.2 percent to $21.65 in pre-market trading. Alibaba and Cainiao agreed to make strategic investment in ZTO Express of $1.38 billion. DHI Group, Inc. (NYSE: DHX) rose 10.8 percent to $2.05 in pre-market trading. Momo Inc. (NASDAQ: MOMO) shares rose 9.6 percent to $42.68 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares rose 9.1 percent to $6.00 in pre-market trading. Universal Display Corporation (NASDAQ: OLED) rose 8.4 percent to $108.00 in pre-market trading. Jupai Holdings Limited (NYSE: JP) shares rose 7 percent to $24.50 in pre-market trading after reporting Q1 results. Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 5.9 percent to $10.61 in pre-market trading. Frontline Ltd. (NYSE: FRO) rose 5.9 percent to $5.04 in pre-market trading. Evogene Ltd. (NASDAQ: EVGN) rose 5.5 percent to $3.27 in pre-market trading after reporting Q1 results. Sears Holdings Corporation (NASDAQ: SHLD) rose 5.5 percent to $3.68 in pre-market trading after gaining 5.44 percent on Friday. Kitov Pharma Ltd (NASDAQ: KTOV) shares rose 5.4 percent to $2.16 in pre-market trading.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
No comments:
Post a Comment